HKD 4.17
(-1.42%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 696.64 Million HKD | 50.66% |
2022 | 464.08 Million HKD | -28.4% |
2021 | 627 Million HKD | 51.56% |
2020 | 295.21 Million HKD | 5.77% |
2019 | 393.31 Million HKD | 47.59% |
2018 | 268.09 Million HKD | -10.86% |
2017 | 300.76 Million HKD | 2.0% |
2016 | 294.87 Million HKD | 18.46% |
2015 | 248.93 Million HKD | 2.59% |
2014 | 242.64 Million HKD | 13.89% |
2013 | 213.05 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 345.84 Million HKD | 6.3% |
2023 Q2 | 364.23 Million HKD | 52.15% |
2023 Q4 | 319.99 Million HKD | -12.15% |
2023 FY | - HKD | 50.66% |
2022 Q4 | 239.39 Million HKD | 11.47% |
2022 FY | - HKD | -28.4% |
2022 Q2 | 214.75 Million HKD | -18.25% |
2021 FY | - HKD | 51.56% |
2021 Q2 | 371.58 Million HKD | 19.69% |
2021 Q4 | 262.69 Million HKD | -29.3% |
2020 Q4 | 310.44 Million HKD | 187.68% |
2020 Q2 | 107.91 Million HKD | -45.53% |
2020 FY | - HKD | 5.77% |
2019 Q2 | 197.59 Million HKD | 102.77% |
2019 FY | - HKD | 47.59% |
2019 Q4 | 198.1 Million HKD | 0.26% |
2018 Q2 | 170.65 Million HKD | 23.13% |
2018 Q4 | 97.44 Million HKD | -42.9% |
2018 FY | - HKD | -10.86% |
2017 Q2 | 162.16 Million HKD | 19.94% |
2017 FY | - HKD | 2.0% |
2017 Q4 | 138.59 Million HKD | -14.54% |
2016 FY | - HKD | 18.46% |
2016 Q2 | 159.67 Million HKD | 33.88% |
2016 Q4 | 135.2 Million HKD | -15.32% |
2015 Q2 | 129.66 Million HKD | 15.02% |
2015 Q4 | 119.26 Million HKD | -8.02% |
2015 FY | - HKD | 2.59% |
2014 Q4 | 112.73 Million HKD | -13.21% |
2014 FY | - HKD | 13.89% |
2014 Q2 | 129.9 Million HKD | 113.23% |
2013 FY | - HKD | 0.0% |
2013 Q4 | 60.92 Million HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kaisa Health Group Holdings Limited | 27.56 Million HKD | -2427.644% |
Elegance Optical International Holdings Limited | -51.64 Million HKD | 1448.883% |
Arts Optical International Holdings Limited | 77.08 Million HKD | -803.711% |
Kelfred Holdings Limited | 14.24 Million HKD | -4790.789% |